News &amp; Updates

Women admitted to the intensive care unit (ICU) suffer worse illness severity and higher ICU mortality risks than men, reports a recent meta-analysis.

Women have more severe disease, greater mortality than men in ICU

Immunosuppression treatment with mTORi carries risk of ovarian cyst

Among women receiving immunosuppression treatment with mammalian target of rapamycin inhibitors (mTORi), the incidence of ovarian cyst appears to be a common adverse event, according to the results of a systematic review and meta-analysis.

Immunosuppression treatment with mTORi carries risk of ovarian cyst

06 Oct 2021

Adaptive vs conventional deep-brain stimulation offers advantages for Parkinson’s disease

A small open-label study supports the safety and motor performance effectiveness of closed-loop adaptive deep-brain stimulation (aDBS) compared with conventional daily deep-brain stimulation (cDBS) sessions in Parkinson’s disease (PD) patients.

Adaptive vs conventional deep-brain stimulation offers advantages for Parkinson’s disease

06 Oct 2021

Extended letrozole therapy improves DFS in postmenopausal women with breast cancer

Extending treatment with letrozole for 5 years improves disease-free survival (DFS) rates in postmenopausal women with early-stage breast cancer who have already received tamoxifen for 2–3 years, according to the GIM4* trial.

Extended letrozole therapy improves DFS in postmenopausal women with breast cancer

06 Oct 2021

1-month DAPT may be enough post-PCI

In patients at high-bleeding risk (HBR) implanted with a drug-eluting coronary stent, 1 month of dual antiplatelet therapy (DAPT) is as good as 3 months or longer – with significantly less bleeding – in the MASTER DAPT* trial, that experts said shorter DAPT post coronary stenting may be the strategy moving forward.

1-month DAPT may be enough post-PCI

Neural stem cell delivery of oncolytic adenovirus feasible in newly diagnosed malignant glioma

A first-in-human, open-label, phase I, dose-escalation trial shows that treatment of newly diagnosed malignant glioma with an engineered oncolytic adenovirus delivered by neural stem cells (NSCs) is feasible and safe.

Neural stem cell delivery of oncolytic adenovirus feasible in newly diagnosed malignant glioma

Smoking ups venous thromboembolism risk in cancer patients

Smoking increases the risk of venous thromboembolism (VTE) in cancer patients, but not in people without cancer, a recent study has found.

Smoking ups venous thromboembolism risk in cancer patients

05 Oct 2021

Thrombectomy a viable first-line therapy for stroke in pregnant women, new mothers

05 Oct 2021 by

In the treatment of women with acute ischaemic stroke, mechanical thrombectomy is effective and can be safely performed during pregnancy or the postpartum period, as shown in a study.

Thrombectomy a viable first-line therapy for stroke in pregnant women, new mothers

05 Oct 2021

Pharmacist expertise may be used to advance nutrition, prevent disease: study

Pharmacists may play a significant role in advancing population-based nutrition care particularly related to chronic conditions, suggests a study.

Pharmacist expertise may be used to advance nutrition, prevent disease: study

Low adherence to CKD-specific diet tied to impaired kidney function, dyslipidaemia

A recent study has identified several factors and biomarkers that contribute to lower adherence to chronic kidney disease (CKD)-specific dietary recommendations.

Low adherence to CKD-specific diet tied to impaired kidney function, dyslipidaemia